Nature reviews. Drug discovery

Nat Rev Drug Discov · ISSN (e) 1474-1784 · 8 papers in corpus
review 2025
doi:10.1038/s41573-025-01172-x ·PMID:40247142

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor originally identified as the target mediating the toxic effects of environmental pollutants including polycyclic aromatic hydrocarbons (PAHs), polychlorinated bi…

review 2023
doi:10.1038/s41573-023-00670-0 ·PMID:36973491

Poor medication adherence is a pervasive issue with considerable health and socioeconomic consequences. Although the underlying reasons are generally understood, traditional intervention strategies rooted in patient-centric education and em…

review 2022
doi:10.1038/s41573-021-00268-4 ·PMID:34526696

Transient receptor potential (TRP) channels are multifunctional signalling molecules with many roles in sensory perception and cellular physiology. Therefore, it is not surprising that TRP channels have been implicated in numerous diseases,…

other 2021
doi:10.1038/d41573-021-00150-3 ·PMID:34475540
review 2019
doi:10.1038/s41573-019-0013-8 ·PMID:30728472

Ion channels play fundamental roles in both excitable and non-excitable tissues and therefore constitute attractive drug targets for myriad neurological, cardiovascular and metabolic diseases as well as for cancer and immunomodulation. Howe…

review 2017
doi:10.1038/nrd.2017.178 ·PMID:29075003

G protein-coupled receptors (GPCRs) are the most intensively studied drug targets, mostly due to their substantial involvement in human pathophysiology and their pharmacological tractability. Here, we report an up-to-date analysis of all GP…

review 2012
doi:10.1038/nrd3800 ·PMID:22850787

Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory syndromes results in a rapid and sustained reduction in disease severi…

other 2010
doi:10.1038/nrd3246 ·PMID:20671753